论文部分内容阅读
治疗慢性下呼吸道感染 慢性下呼吸道感染主要波及全肺细支气管,开始可能感染肺炎球菌或流感杆菌;日久不愈,环境中绿脓杆菌即可乘机而入,大量增殖并在细支气管壁粘膜形成一层细菌薄膜,使抗菌药物无法侵入其膜内杀死细菌,体内各种免疫物质也无法接近,从而使病情不断恶化,出现呼吸功能障碍。对此种慢性感染常束手无策。80年代初国外一位科学家发现此类感染应用红霉素治疗有效,进入90年代从临床上又得到充分证明,并对其治疗机制进行了研究。它的主要作用除抗菌功能外,还有:
Treatment of chronic lower respiratory tract infection Chronic lower respiratory tract infection mainly affects the whole lung bronchioles, the beginning may be infected with pneumococcal or influenza bacilli; untimely, Pseudomonas aeruginosa environment can take the opportunity to enter, a large number of proliferation and in the bronchial wall mucosa formation A layer of bacterial film, antimicrobial drugs can not invade the membrane to kill bacteria, the body can not access a variety of immune substances, so that the condition deteriorating, respiratory dysfunction. This kind of chronic infection often do nothing. In the early 1980s, a foreign scientist discovered that erythromycin was effective in treating such infections. From the 1990s to the present, it has been fully proved clinically and its therapeutic mechanism has been studied. Its main role in addition to anti-bacterial function, there are: